Vivos Therapeutics, Inc.

US$0.09As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VVOSHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (71.58%)
Div yield —
ROE (8585.26%)
Medical Devices
Beta (5Y) 6.30
PE TTM —
TSR TTM (96.37%)
Mkt cap US$1.885M
ROIC (114.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.112
19.66%
42.70%
Hold 12|7|6|5|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
(0.64%)
(11.64%)
(6.92%)
2.90%
Revenue$M
0.099
0.102
0.101
0.102
6.19%
10.86%
5.47%
7.67%
Peers (US$1.885M)
Cap (US$)
PE
2.126M
—
1.856M
—
Capital
TTM
5Y
10Y
Leveragex
0.192
(0.172)
(0.162)
EBIT/Intx
0.302
0.226
0.177
Own earn%
(182.88)
228.66
200.55
Sh yield%
36.06
29.62
29.44
Owners
Insiders/Inst%
3.09
48.56
Short interest%
0.95
SBC / revenue%
4.77
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
11